SHP141
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHP141, covering 2016-03-24 to 2016-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL) [Phase 1]